• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

(2025) New Approach Methodologies (NAMs) for Modeling Kidney Function, Disease and Drug Response

On-demand Webinar

Chronic kidney disease (CKD) and other renal disorders impact more than 10% of the world population worldwide, posing a growing public health burden with limited treatment options and a notable lack of targeted therapies. Despite significant research efforts, the translation of preclinical findings into effective clinical treatments remains a major hurdle. New Approach Methodologies (NAMs), such as complex 3D in vitro models, offer more predictive and mechanistic insights into kidney function, disease progression, and drug response. By replicating human-relevant renal physiology and integrating key components like the immune system, NAMs may bridge the translational gap between preclinical findings and effective treatments.

Watch our on-demand webinar with Linda Gijzen (Scientific Project Lead, MIMETAS) to discover how human-relevant 3D in vitro models are advancing renal research and accelerating the development of novel, targeted therapies for diseases such as CKD.

Webinar highlights:

  • Latest advances in 3D human kidney models using the OrganoPlate® with integrated immune components such as monocytes, macrophages and T cells, and mechanistic insights into renal function and pathology.
  • Applications in drug development, including toxicity screening, target discovery/ validation, as well as testing of novel compounds.
  • Case study about a complex kidney-on-a-chip model that captures immune interactions relevant to renal inflammation, including testing novel immunomodulant therapeutics to study drug response.

Access the recording here!

 


Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all